(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENVISIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ENVISIX

ST13

US500000090375549

Class

35, 42

Filing

90375549

Registration

7127768

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

04/03/2025

Trademark type

Combined

Nice classes

35, 42

Filing date

12/11/2020

Registration date

08/01/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/01/2023

Last transaction

04/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/31/2022

First use in commerce

03/31/2022

Drawing code

5

Owner type

16

Owner location

WILMINGTON, DE

Examiner

FERRAIUOLO, DOMINIC

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "EnvisiX" in which the "En" lettering is shown in dark green and the "visiX" lettering is shown in light green.

Holders and representatives

Holders

GREENPHIRE, LLC
Greenphire, Inc.

Representatives

GREGORY S. BERNABEO FISHERBROYLES LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

providing an online computer database in the field of clinical trialsfor business purposes

Class 42

software as a service (SAAS) solutions featuring nondownloadable software for the collectioninterpretationtracking and viewing of cost data in the field of clinical trials; software as a service (SAAS) solutions featuring non-downloadable software for use in managing data and information in the field of medical clinical trials; software as a service (SAAS) solutions featuring non-downloadable software for use to forecast and benchmark budgets and costs in medical clinical trials; software as a service (SAAS) solutions featuring non-downloadable software for the development of clinical trial cost estimates and budgets

Publications

History of USPTO decisions and trademark events.

48 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/02/2025

EXPT

EXPARTE APPEAL TERMINATED

08/16/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/01/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/30/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/29/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/28/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/28/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/28/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/28/2023

GNRT

NON-FINAL ACTION E-MAILED

06/28/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

06/28/2023

EXPI

EX PARTE APPEAL-INSTITUTED

06/06/2023

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

06/06/2023

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

06/06/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/21/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

02/20/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

02/20/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/07/2022

GNFR

FINAL REFUSAL E-MAILED

12/07/2022

CNFR

SU - FINAL REFUSAL - WRITTEN

12/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/04/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/04/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/04/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/23/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/06/2022

GNRT

NON-FINAL ACTION E-MAILED

06/06/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

06/06/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/17/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/17/2022

IUAF

USE AMENDMENT FILED

05/05/2022

EISU

TEAS STATEMENT OF USE RECEIVED

05/05/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/28/2022

EX1G

SOU EXTENSION 1 GRANTED

01/26/2022

EXT1

SOU EXTENSION 1 FILED

01/26/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/26/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/27/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/01/2021

PUBO

PUBLISHED FOR OPPOSITION

06/01/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/12/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/27/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

04/27/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/27/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

04/27/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/27/2021

DOCK

ASSIGNED TO EXAMINER

04/27/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2021

NWAP

NEW APPLICATION ENTERED

12/15/2020

Continuous trademark protection

Get notified about every new filing that threatens ENVISIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.